FIT screening

Colorectal cancer (CRC) is one of the most frequently diagnosed cancers. The good news is that CRC incidence and mortality can be reduced significantly if detected early enough.

Faecal immunochemical tests (FIT) are non-invasive and can detect blood in stool invisible to the naked eye. Due to its simplicity, FIT is currently considered the best non-invasive test for CRC screening.

Invest a little time in your own health by taking the FIT to prevent or detect colon cancer early on.
For further information, please visit our ‘FIT for screening’ website www.fitscreening.eu/patients

 

 

Please select your country. This will keep you up to date with your country-specific information.

OSNA in breast cancer

  • Precise lymph node analysis providing accurate staging
  • Reliable diagnostic information for therapy decision
  • High flexibility in multi-cancer application (CE-marked for breast, colon and gastric cancer)

Documents

All
  • All
  • Literature
Documents

More differentiated information to fine-tune your treatment decision

Axillary management and the relevance of sentinel lymph node biopsy (SLNB) have undergone major changes in the last years. Clinical trials, which have investigated less invasive treatment approaches as a replacement of axillary surgery, indicate that axillary dissection can be omitted in patients with limited metastatic involvement. Consequently, treatment decisions and nodal staging more often have to be based solely on the diagnostic information derived from the sentinel lymph node (SLN).

More than 100 publications provide evidence on the clinical utility of using OSNA and the CK19 copy number for SLN assessment. They show that CK19 provides predictive and prognostic information beyond conventional pathology assessment. This helps clinicians better select who can be safely spared an ALND, allows more personalised treatment decisions and improves patients’ quality of life.

Oncology

Do you get all this from your current sentinel lymph node analysis?

Do you get all this from your current sentinel lymph node analysis?

CK19 mRNA expression level:

Choose OSNA and fine-tune your treatment decision

Choose OSNA and fine-tune your treatment decision

Publications

Publications

Please see our publication list

Contact

Sysmex Europe GmbH

+49 (40) 527 26 0
+49 (40) 527 26 100
info@sysmex-europe.com
Bornbarch 1
22848 Norderstedt
Germany

Create Pdf

Learn how intraoperative sentinel lymph node analysis benefits cancer patients

Watch Penny’s story

Walk-Away FIT solutions for high throughput

Watch video

A step forward in colorectal cancer monitoring

Watch Carmen’s story
Enjoy our Media Centre
All
  • All
  • Documents
  • Podcast
  • Images
  • Videos
See our collection
Company movie